Skip to content
Screener

Vanda Pharmaceuticals VNDA Q4 2025 Annual earnings

Reported February 11, 2026 · After market close

Revenue$57.2MMiss by $2.1M
EPS-$0.46Beat by $1.72
Revenue estimate$59.3M
EPS estimate-$2.18

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$69.3M
EPS estimate-$0.72

FAQ

When did Vanda Pharmaceuticals report Q4 2025 earnings?
Vanda Pharmaceuticals (VNDA) reported Q4 2025 earnings on February 11, 2026 after market close.
What were Vanda Pharmaceuticals's Q4 2025 revenue and EPS?
Vanda Pharmaceuticals reported revenue of $57.2M and eps of $-0.46 for Q4 2025.
Did Vanda Pharmaceuticals beat estimates in Q4 2025?
Revenue missed the consensus estimate of $59.3M by $2.1M. EPS beat the consensus estimate of $-2.18 by $1.72.
How did Vanda Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.6% from $53.2M a year earlier and eps declined 475.0% from $-0.08.
Where can I find Vanda Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-007256) and the 10-K periodic report (0001628280-26-007460) directly on SEC EDGAR. The filing index links above go to sec.gov.